Abstract
Previous studies demonstrated that preincubation of membranes from the brain of the rat with 1μM (+)- cis-3-methylfentanyl produced a wash-resistant inhibition of μ receptor binding. The present study was designed to: (1) determine the mechanism by which (+)- cis-3-methylfentanyl produced a wash-resistant inhibition of μ receptor binding, and (2) to generate a structure-activity study, using wash-resistant inhibition as the end-point. Pretreatment of membranes with 500 nM (+)- cis-3-methylfentanyl increased the K d of binding sites for [ 3H]ohmefentanyl, without altering the B max,. The increase in the K d was only partially due to the presence of residual drug and was accompanied by an increase in the dissociation rate of the binding of [ 3H]ohmefentanyl. Therefore, pretreatment of membranes with (+)- cis-3-methylfentanyl resulted in a lower affinity interaction of [ 3H]ohmefentanyl with the μ binding site, consistent with a model postulating pseudoallosteric modulation of μ binding sites by (+)- cis-3-methylfentanyl and its analogs. The rank order of potencies for wash-resistant inhibition of the binding of [ 3H]6β-fluoro-6-desoxyoxymorphone or [ 3H]ohmefentanyl, was lofentanil >(+)- cis-3-methylfentanyl > ohmefentanyl > sufentanil. All other opioids tested (1 μM morphine, 1 μM naloxone, 1μM fentanyl, 1 μM (+)-cyclazocine, 1 μM (−)- cis-3-methylfentanyl) did not act as wash-resistant inhibitors of μ binding sites. Although the pseudoirreversible IC 50, of these agents did not correlate with their ED 50 values for producing antinociception, after intravenous administration, the authors speculate that this property, termed “pseudoirreversible inhibition”, might contribute to the extraordinary potency of (+)- cis-3-methylfentanyl and its analogs as antinociceptive agents.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.